West Paces Advisors’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.24K Buy
127
+36
+40% +$608 ﹤0.01% 563
2026
Q2
$1.44K Buy
+91
New +$1.41K ﹤0.01% 626
2025
Q2
– Sell
-29
Closed -$253 – 552
2025
Q1
$253 Hold
29
– – ﹤0.01% 545
2024
Q4
$361 Hold
29
– – ﹤0.01% 533
2024
Q3
$337 Hold
29
– – ﹤0.01% 529
2024
Q2
$308 Hold
29
– – ﹤0.01% 545
2024
Q1
$346 Hold
29
– – ﹤0.01% 560
2023
Q4
$314 Hold
29
– – ﹤0.01% 585
2023
Q3
$286 Sell
29
-34
-54% -$354 ﹤0.01% 507
2023
Q2
$629 Hold
63
– – ﹤0.01% 517
2023
Q1
$606 Sell
63
-757
-92% -$8.4K ﹤0.01% 528
2022
Q4
$9.13K Buy
820
+757
+1,202% +$7.91K ﹤0.01% 359
2022
Q3
$537 Hold
63
– – ﹤0.01% 496
2022
Q2
$660 Sell
63
-35
-36% -$384 ﹤0.01% 539
2022
Q1
$1.07K Buy
+98
New +$1.29K ﹤0.01% 527

Other funds holding VTRS

West Paces Advisors's VTRS Position: Q3 2026 in Review

West Paces Advisors increased its Viatris (VTRS) stake by 40% in Q3 2026, buying an estimated $608 and bringing the position to 127 shares worth $2.24K. The position accounts for ﹤0.01% of the portfolio, ranked #563.

West Paces Advisors first reported a position in VTRS in Q1 2022 and has held it in 15 quarters since. The position peaked at $9.13K in Q4 2022. 229 funds tracked by Wall St. Rank hold VTRS as of Q3 2026.

  • West Paces Advisors held 127 shares of Viatris worth $2.24K as of Q3 2026.
  • West Paces Advisors bought 36 Viatris shares in Q3 2026, an estimated $608.
  • Viatris made up ﹤0.01% of West Paces Advisors's portfolio in Q3 2026, its #563 holding.
  • West Paces Advisors first reported a position in Viatris in Q1 2022 and has held it in 15 quarters since.
  • West Paces Advisors's Viatris position peaked at $9.13K in Q4 2022.
  • 229 funds tracked by Wall St. Rank held Viatris as of Q3 2026.

Based on West Paces Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.